Background and Objective The γ-secretase inhibitor (GSI) has been shown to inhibit expression of amyloid beta (Aβ), but GSI also has a side effect of reducing cell survival. Since low-power laser irradiation (LLI) has been known to promote cell survival, we examined whether 532 nm LLI can rescue the GSI side effect or not. Study Design/Materials and Methods The human-derived glioblastoma cells (A-172) were cultured in 35 mm culture dishes or 96-well plate. The center of dish or selected wells was irradiated with 532 nm laser (Nd:YVO4, CW, 60 mW) for 20, 40 and 60 min, respectively. The irradiated cells were photographed at immediately after, 24 and 48 h later and counted. GSI was supplemented in medium 3 h before LLI. The MTT assay was also used to estimate viable cells at 48 h after irradiation. The expression of phosphorylated Akt (p-Akt) or phosphorylated PTEN (p-PTEN) was examined by immunofluorescent staining and measured by fluorescence intensity using the software (BZ-9000, KEYENCE, Japan). Results GSI application depressed cell proliferation as well as cell survival compared to control. GSI down-regulated Aβ but up-regulated p-PTEN and suppressed p-Akt. Application of 532 nm LLI in the presence of GSI significantly recovered the GSI-mediated effects, i.e., LLI could decrease elevated p-PTEN, while increased p-Akt expression with keeping Aβ suppression. The LLI effects had a dose-dependency. Conclusion We confirmed that GSI potently suppressed intracellular Aβ and decreased cell survival. We conclude that a combination of GSI application and 532 nm LLI can increase cell proliferation via Akt activation while keeping PTEN and Aβ suppressed.
References
[1]
Prince M, Jackson J (2009) Alzheimer’s Disease International World Alzheimer Report. Grobal Action on Aging site. Available: http://www.globalaging.org/health/world/？2009/alzheimer.pdf. Accessed 2013 Jan 10.
[2]
Li M, Chen L, Lee DH, Yu LC, Zhang Y (2007) The role of intracellular amyloid β in Alzheimer's disease. Progress in Neurobiology 83: 131–139.
[3]
Zhao H, Zhu J, Cui K, Xu X, O'Brien M, et al. (2009) Bioluminescence imaging reveals inhibition of tumor cell proliferation by Alzheimer's amyloid β protein. Cancer Cell Int 1: 9–15.
[4]
Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P, et al. (2001) Functional γ-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76: 173–181.
[5]
Wolfe MS, De Los Angeles J, Miller DD, Xia W, Selkoe DJ (1999) Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. Biochemistry 38: 11223–11230.
[6]
Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P, et al. (2001) Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 76: 173–81.
[7]
De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, et al. (1999) A presenilin-1-dependent g-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518–522.
[8]
Greenwald I (1998) LIN-12/Notch signaling: lessons from worms and flies. Genes Dev 12: 1751–1762.
[9]
Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284: 770–776.
[10]
Conlon RA, Reaume AG, Rossant J (1995) Notch1 is required for the coordinate segmentation of somites. Development 121: 1533–1545.
[11]
Gutierrez A, Look AT (2007) Notch and PI3K-Akt Pathways Intertwined. Cancer Cell 12: 411–413.
[12]
Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, et al. (2007) Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nature Med 13: 1203–1210.
[13]
Mester E, Juhász J, Varga P, Karika G (1968) Lasers in clinical practice. Acta Chir Acad Sci Hung 9: 349–357.
[14]
Karu T (1989) Photobiology of low-power laser effect, Health Physics. 56: 691–704.
[15]
da Silva JP, da Silva MA, Almeida AP, Lombardi Junior I, Matos AP (2010) Laser therapy in the tissue repair process: a literature review. Photomed Laser Surg 28: 17–21.
[16]
Brosseau L, Robinson V, Wells G, Debie R, Gam A, et al. (2005) Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev DOI: 10.1002/14651858.CD002049.pub2.
[17]
Bjordal JM, Lopes-Martins RA, Joensen J, Couppe C, Ljunggren AE, et al. (2008) A systematic review with procedural assessments and meta-analysis of low level laser therapy in lateral elbow tendinopathy (tennis elbow). BMC M Disorders DOI: 10.1186/1471-2474-9-75.
[18]
Jamtvedt G, Dahm KT, Christie A, Moe RH, Haavardsholm E, et al. (2007) Physical therapy interventions for patients with osteoarthritis of the knee: an overview of systematic reviews. Phys Ther 88: 123–136.
[19]
Kassák P, Przygodzki T, Habodászová D, Bryszewska M, Sikurová L (2005) Mitochondrial alterations induced by 532 nm laser irradiation. Gen Physiol Biophys 24: 209–220.
[20]
Gresner P, Wata？a C, Sikurová L (2005) The effect of green laser light irradiation on whole blood platelets. J Photochem Photobiol B 79: 43–50.
[21]
Liang J, Liu L, Xing D (2012) Photobiomodulation by low-power laser irradiation attenuates Aβ-induced cell apotosis through the Akt/GSK3β/β-catenin pathway. Free Radic Biol Med 53(7): 1459–1467.
[22]
Stocker H, Andjelkovic M, Oldham S, Laffargue M, Wymann, et al (2002) Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science 15 295(5562): 2088–91.
[23]
Pancewicza J, Taylora JM, Dattaa A, Baydouna HH, Waldmann TA, et al. (2010) Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc Natl Acad Sci USA 107(38): 16619–24.
[24]
Murayama H, Sadakane K, Yamanoha B, Kogure S (2012) Low-power 808-nm laser irradiation inhibits cell proliferation of a human-derived glioblastoma cell line in vitro. Lasers Med Sci 27: 87–93.
[25]
Ang FY, Fukuzaki Y, Yamanoha B, Kogure S (2011) Immunocytochemical studies on the effect of 405-nm low-power laser irradiation on human-derived A-172 glioblastoma cell. Lasers Med Sci 27: 935–942.
[26]
Cavett W, Tucci M, Cason Z, Lemos L, England B, et al. (1997) Comparison of cellular responses induced by low level light in different cell types. Biomed Sci Instrum 33: 155–60.
[27]
Karu T (2003) Low Power Laser Therapy. Biomedical Photonics Handbook 48: CRC Press. 48 p.
[28]
Gao X, Xing D (2009) Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci DOI:10.1186/1423-0127-16-4.
[29]
McBride HM, Neuspiel M, Wasiak S (2006) Mitochondria: more than just a powerhouse. Curr Biol 16: 551–560.
[30]
Shefer G, Oron U, Irintchev A, Wernig A, Halevy O (2001) Skeletal muscle cell activation by low-energy laser irradiation: a role for the MAPK/ERK pathway. J Cell Physiol 187: 73–80.
Shefer G, Partridge TA, Heslop L, Gross JG, Oron U, et al. (2002) Low-energy laser irradiation promotes the survival and cell cycle entry of skeletal muscle satellite cells. J Cell Sci 115: 1461–1469.
[35]
Azevedo LH, de Paula Eduardo F, Moreira MS, de Paula Eduardo C, Marques MM (2006) Influence of different power densities of LILT on cultured human fibroblast growth. Lasers Med Sci DOI 10.1007/s10103-006-0379-9.
[36]
Bijur GN, Jope RS (2003) Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem 87: 1427–1435.
[37]
Miyamoto S, Murphy AN, Brown JH (2008) Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ 15: 521–529.
[38]
Su CC, Yang JY (2012) Mitochondrial Aktregulated mitochondrial apoptosis signaling in cardiac muscle cells. Am J Physiol Heart Circ Physiol 302: 716–23.
[39]
Karu T (2008) Mitochondrial Signaling in Mammalian Cells Activated by Red and Near-IR Radiation. Photochem Photobiol 84: 1091–1099.
[40]
Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, et al. (2003) The role of presenilin cofactors in the gamma-secretase complex. Nature 422: 438–441.
[41]
Panza F, Solfrizzi V, Frisardi V, Capurso C, D'Introno A, et al.. (2009) Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging DOI: 10.2165/11315770-000000000-00000.
[42]
Chan SM, Weng AP, Tibshirani R, Aster JC, Utz PJ (2007) Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 110: 278–286.
